Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Monte Rosa Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 53 | 52 | −1 |
| Shares | 36.3M | 39.9M | +3.60M (+9.9%) |
| Value | $742.0M | $559.9M | −$182.1M (−24.5%) |
New holders (10)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allianz Asset Management GmbH | 92,497 | $1.30M | 0.00% |
| Manufacturers Life Insurance Company, The | 92,217 | $1.26M | 0.00% |
| Rhumbline Advisers | 24,192 | $339.0K | 0.00% |
| Laurion Capital Management LP | 23,252 | $326.0K | 0.01% |
| MetLife Investment Management | 18,157 | $254.6K | 0.00% |
| ProShare Advisors LLC | 10,230 | $144.0K | 0.00% |
| Barclays PLC | 9,108 | $128.0K | 0.00% |
| Amalgamated Bank | 2,832 | $40.0K | 0.00% |
| Amalgamated Financial Corp. | 2,832 | $40.0K | 0.00% |
| Metropolitan Life Insurance Co | 2,127 | $29.8K | 0.00% |
Sold out (11)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jennison Associates LLC | 530,065 | $10.8M |
| Avidity Partners Management LP | 300,000 | $6.13M |
| Octagon Capital Advisors LP | 150,000 | $3.06M |
| Voya Investment Management LLC | 95,355 | $1.95M |
| Ergoteles LLC | 74,510 | $1.52M |
| Prudential Financial Inc | 73,845 | $1.51M |
| EcoR1 Capital, LLC | 37,593 | $768.0K |
| D. E. Shaw & Co., Inc. | 24,085 | $492.0K |
| DekaBank Deutsche Girozentrale | 15,000 | $293.0K |
| SG Americas Securities, LLC | 6,621 | $135.0K |
| Migdal Insurance & Financial Holdings Ltd. | 124 | $3.00K |